08/12 | Columbia Care Inc. Launches First Pre-Rolls in New York Under Its Leading National Flower Brand, Seed & Strain | CI |
08/12 | Shilpa Medicare Limited Announces Board Changes | CI |
08/12 | Applied Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 | CI |
08/12 | Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 | CI |
08/12 | Aptinyx Inc. Reports Results from Phase 2b Study of NYX-2925 in Fibromyalgia | CI |
08/12 | Venus Concept Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 | CI |
08/12 | Leap Therapeutics, Inc. Resigns Dr. Monica Bertagnolli, as Director | CI |
08/12 | Instil Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 | CI |
08/12 | Venus Concept Inc. Provides Revenue Guidance for the Twelve Months Ending December 31, 2022 | CI |
08/12 | Asiri Hospital Holdings PLC Reports Earnings Results for the First Quarter Ended June 30, 2022 | CI |
08/12 | MicroPort Scientific Corporation Announces Change of Address of Principal Place of Business in Hong Kong | CI |
08/12 | Rapid Micro Biosystems, Inc. Revises Earnings Guidance for the Full Year 2022 | CI |
08/12 | Bruker Approves Payment of Quarterly Cash Dividend, Payable September 16, 2022 | CI |
08/12 | Unity Biotechnology Announces Positive Data in Phase 2 Behold Study of Ubx1325 in Patients with Diabetic Macular Edema | CI |
08/12 | Ascend Wellness Holdings, Inc. Opens of Its Fort Lee, New Jersey Dispensary for Medical Patients Located At 461 West Street, Fort Lee, NJ 07024 | CI |
08/12 | CASI Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 | CI |
08/12 | Rapid Micro Biosystems, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 | CI |
08/12 | Humacyte, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 | CI |
08/12 | Dentalcorp Holdings Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 | CI |
08/12 | PLx Pharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 | CI |
08/12 | EVOTEC : Receives a Buy rating from Warburg Research | MD |
08/12 | SYNLAB : Deutsche Bank reiterates its Buy rating | MD |
08/12 | AsiaMedic Limited Reports Earnings Results for the Half Year Ended June 30, 2022 | CI |
08/12 | ASLAN Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended June 30, 2022 | CI |
08/12 | Unity Biotechnology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 | CI |
08/12 | Leap Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 | CI |
08/12 | Pfizer Inc. Announces Positive Top-Line Results from Phase 3 Study of 20-Valent Pneumococcal Conjugate Vaccine in Infants | CI |
08/12 | Bayer Shares Climb After Arbitration Tribunal Dismisses BASF Claims | DJ |
08/12 | Wockhardt Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 | CI |
08/12 | STRATEC BIOMEDICAL SYSTEMS AG : Deutsche Bank maintains a Buy rating | MD |
08/12 | Pharmesis International Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 | CI |
08/12 | QIAGEN NV : Deutsche Bank reiterates its Buy rating | MD |
08/12 | Coral Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 | CI |
08/12 | Second Sight Medical Products, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 | CI |
08/12 | Kiora Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 | CI |
08/12 | EVOTEC : Buy rating from Deutsche Bank | MD |
08/12 | HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Half Year Ended June 30, 2022 | CI |
08/12 | Sonida Senior Living, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 | CI |
08/12 | GenXone S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 | CI |
08/12 | Star Equity Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 | CI |
08/12 | Rebus Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 | CI |
08/12 | Suntar Eco-City Limited Reports Earnings Results for the Half Year Ended June 30, 2022 | CI |
08/12 | AirSculpt Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 | CI |
08/12 | Universal Vision Biotechnology Co., Ltd. Announces Change of the Principal Financial and Accounting Officer | CI |
08/12 | Airsculpt Technologies, Inc. Anticipates Opening Two Additional Centers | CI |
08/12 | AirSculpt Technologies, Inc. Provides Revenue Guidance for the Full Year 2022 | CI |
08/12 | AirSculpt Technologies, Inc. Declares Special Dividend, Payable on September 14, 2022 | CI |
08/12 | CARsgen Therapeutics Holdings Limited Announces Change of Address of Principal Place of Business in Hong Kong | CI |
08/12 | Berry Genomics Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022 | CI |
08/12 | Chemcrux Enterprises Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 | CI |